Metabolic interactions between hyperhomocysteinemia and endothelin-1 among Tunisian patients with acute coronary diseases

[1]  L. Quan,et al.  The up-regulation of endothelin-1 and down-regulation of miRNA-125a-5p, -155, and -199a/b-3p in human atherosclerotic coronary artery. , 2014, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[2]  F. Gao,et al.  Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemia. , 2014, Atherosclerosis.

[3]  S. Paltrinieri,et al.  Big-endothelin 1 (big ET-1) and homocysteine in the serum of dogs with chronic kidney disease. , 2013, Veterinary journal.

[4]  M. Matsuda,et al.  Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. , 2013, Obesity research & clinical practice.

[5]  A. Miled,et al.  Low erythrocyte catalase enzyme activity is correlated with high serum total homocysteine levels in tunisian patients with acute myocardial infarction , 2013, Diagnostic Pathology.

[6]  A. Miled,et al.  [Metabolic interactions between the hyperhomocysteinemia and angiotensin-1 converting enzyme activity in Tunisian patients with coronary heart disease]. , 2012, Annales de biologie clinique.

[7]  M. Walczak,et al.  Determination of endothelin-1 in rats using a high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. , 2010, Talanta.

[8]  S. Arora,et al.  Homocysteine and lipoprotein (a) correlation in ischemic stroke patients , 2009, Journal of the Neurological Sciences.

[9]  S. Hammami,et al.  Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome. , 2009, Clinical Biochemistry.

[10]  F. Facchinetti,et al.  Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study. , 2009, Fertility and sterility.

[11]  F. Trivin,et al.  Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease. , 2009, Clinical biochemistry.

[12]  F. Trivin,et al.  Hyperhomocysteinaemia and parameters of antioxidative defence in Tunisian patients with coronary heart disease , 2008, Annals of clinical biochemistry.

[13]  Liansheng Wang,et al.  Endothelin-converting enzyme-1b C-338A polymorphism is associated with the increased risk of coronary artery disease in Chinese population. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[14]  D. Webb,et al.  Impaired effect of endothelin-1 on coronary artery stiffness in type 2 diabetes. , 2006, International journal of cardiology.

[15]  A. Scheen,et al.  Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms. , 2004, Diabetes & metabolism.

[16]  J. Aubert,et al.  Measurement of plasma endothelin-1 in experimental hypertension and in healthy subjects. , 2003, American journal of hypertension.

[17]  S. Hercberg,et al.  L’hyperhomocystéinémie : facteur de risque cardiovasculaire ou simple marqueur ? ☆: 2. Données épidémiologiques , 2003 .

[18]  J. Guilland,et al.  [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data]. , 2003, Pathologie-biologie.

[19]  N. Moatti,et al.  Homocysteine decreases endothelin-1 expression by interfering with the AP-1 signaling pathway. , 2002, Free radical biology & medicine.

[20]  R. Scognamiglio,et al.  Postextrasystolic potentiation echocardiography in predicting reversible myocardial dysfunction by surgical coronary revascularization. , 1998, The American journal of cardiology.

[21]  S. Grundy,et al.  Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men. , 1998, The American journal of cardiology.

[22]  G. Cornelissen,et al.  Endothelin-1's Chronome Indicates Diabetic and Vascular Disease Chronorisk , 1997, Peptides.

[23]  T. Yamaji,et al.  Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy. , 1994, Diabetes research and clinical practice.

[24]  D. V. Van Wagoner,et al.  The significance of circulating endothelin-1 as a predictor of coronary artery disease status and clinical outcomes following coronary artery catheterization. , 2015, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[25]  P. Galan,et al.  [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease? 2. Epidemiological data]. , 2003, Pathologie-biologie.